IN006

· Shenzhen Shenxin Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IN006, covering 2025-09-09 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults [Phase 1]

See pricing